IFN-β Inhibits the Increased Expression of IL-9 during Experimental Autoimmune Uveoretinitis

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Yang, Yan ^a,b   Du, Liping ^b   Sun, Min ^b   Kijlstra, Aize ^c   Yang, Peizeng ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD3 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE UVEORETINITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DRAINING LYMPH NODE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; LYMPH NODE CELL; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; SPLEEN CELL; TH1 CELL; TH17 CELL; UVEORETINITIS;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; EYE PROTEINS; IMMUNOLOGIC MEMORY; INTERFERON-BETA; INTERLEUKIN-9; MICE; MONOCYTES; RETINITIS; RETINOL-BINDING PROTEINS; TH1 CELLS; TH17 CELLS;

MUS;

EID: 84868159463     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048566     Document Type: Article

References (34)

1. Caspi RR, (2011) Understanding autoimmune uveitis through animal models. The Friedenwald Lecture. Invest Ophthalmol Vis Sci 52: 1872-1879.
2. Wacker WB, Donoso LA, Kalsow CM, Yankeelov JA Jr, Organisciak DT, (1977) Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol 119: 1949-1958.
3. Gery I, Wiggert B, Redmond TM, Kuwabara T, Crawford MA, et al. (1986) Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest Ophthalmol Vis Sci 27: 1296-1300.
4. Donoso LA, Merryman CF, Sery T, Sanders R, Vrabec T, et al. (1989) Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis. J Immunol 143: 79-83.
5. Hu LH, Redmond TM, Sanui H, Kuwabara T, McAllister CG, et al. (1989) Rat T-cell lines specific to a nonimmunodominant determinant of a retinal protein (IRBP) produce uveoretinitis and pinealitis. Cell Immunol 122: 251-261.
6. Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, et al. (1988) A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 140: 1490-1495.
7. Luger D, Silver PB, Tang J, Cua D, Chen Z, et al. (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205: 799-810.
8. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, et al. (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13: 711-718.
9. Peng Y, Han G, Shao H, Wang Y, Kaplan HJ, et al. (2007) Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 48: 4153-4161.
10. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, et al. (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9: 1347-1355.
11. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, et al. (2008) Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9: 1341-1346.
12. Knoops L, Renauld JC, (2004) IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 22: 207-215.
13. Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, et al. (2009) IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A 106: 12885-12890.
14. Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, et al. (2009) IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 206: 1653-1660.
15. Li H, Nourbakhsh B, Cullimore M, Zhang GX, Rostami A, (2011) IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system. Eur J Immunol 41: 2197-2206.
16. Sun M, Yang Y, Yang P, Lei B, Du L, et al. (2011) Regulatory effects of IFN-beta on the development of experimental autoimmune uveoretinitis in B10RIII mice. PLoS One 6: e19870.
17. Caspi RR (2003) Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol Chapter 15: Unit 15 16.
18. Sun M, Yang P, Du L, Zhou H, Ren X, et al. (2010) Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 51: 383-389.
19. Xu H, Rizzo LV, Silver PB, Caspi RR, (1997) Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol 178: 69-78.
20. Tripathi P, Saxena S, Yadav VS, Naik S, Singh VK, (2004) Human S-antigen: peptide determinant recognition in uveitis patients. Exp Mol Pathol 76: 122-128.
21. Ang M, Cheung G, Vania M, Chen J, Yang H, et al. (2012) Aqueous cytokine and chemokine analysis in uveitis associated with tuberculosis. Mol Vis 18: 565-573.
22. Tan C, Aziz MK, Lovaas JD, Vistica BP, Shi G, et al. (2010) Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J Immunol 185: 6795-6801.
23. Zhang X, Jin J, Tang Y, Speer D, Sujkowska D, et al. (2009) IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J Immunol 182: 3928-3936.
24. Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S, (2009) IFN-beta inhibits human Th17 cell differentiation. J Immunol 183: 5418-5427.
25. Durelli L, Conti L, Clerico M, Boselli D, Contessa G, et al. (2009) T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann Neurol 65: 499-509.
26. Sun M, Yang P, Du L, Zhou H, Ren X, et al. (2010) Increased Regulatory T Cells in Spleen during Experimental Autoimmune Uveoretinitis. Ocul Immunol Inflamm 18: 38-43.
27. Milo R, Panitch H, (1995) Additive effects of copolymer-1 and interferon beta-1b on the immune response to myelin basic protein. J Neuroimmunol 61: 185-193.
28. Krakauer M, Sorensen P, Khademi M, Olsson T, Sellebjerg F, (2008) Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Mult Scler 14: 622-630.
29. Byrnes AA, McArthur JC, Karp CL, (2002) Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production. Ann Neurol 51: 165-174.
30. Zhou Y, Sonobe Y, Akahori T, Jin S, Kawanokuchi J, et al. (2011) IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J Immunol 186: 4415-4421.
31. Stephens GL, Swerdlow B, Benjamin E, Coyle AJ, Humbles A, et al. (2011) IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease. Eur J Immunol 41: 952-962.
32. Li H, Nourbakhsh B, Ciric B, Zhang GX, Rostami A, (2010) Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J Immunol 185: 4095-4100.
33. Steenwinckel V, Louahed J, Lemaire MM, Sommereyns C, Warnier G, et al. (2009) IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J Immunol 182: 4737-4743.
34. Elyaman W, Bassil R, Bradshaw EM, Orent W, Lahoud Y, et al. (2012) Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity 36: 623-634.